# Study of Remdesivir in Participants Below 18 Years Old With COVID-19

> **NCT04431453** · PHASE2,PHASE3 · COMPLETED · sponsor: **Gilead Sciences** · enrollment: 59 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Remdesivir

## Key facts

- **NCT ID:** NCT04431453
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-21
- **Primary completion:** 2023-02-10
- **Final completion:** 2023-02-10
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2024-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04431453

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04431453, "Study of Remdesivir in Participants Below 18 Years Old With COVID-19". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT04431453. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*